1. Home
  2. SILO vs LGHL Comparison

SILO vs LGHL Comparison

Compare SILO & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SILO
  • LGHL
  • Stock Information
  • Founded
  • SILO 2010
  • LGHL 2015
  • Country
  • SILO United States
  • LGHL Singapore
  • Employees
  • SILO N/A
  • LGHL N/A
  • Industry
  • SILO Apparel
  • LGHL Investment Bankers/Brokers/Service
  • Sector
  • SILO Consumer Discretionary
  • LGHL Finance
  • Exchange
  • SILO Nasdaq
  • LGHL Nasdaq
  • Market Cap
  • SILO 4.7M
  • LGHL 4.3M
  • IPO Year
  • SILO N/A
  • LGHL N/A
  • Fundamental
  • Price
  • SILO $1.96
  • LGHL $0.16
  • Analyst Decision
  • SILO
  • LGHL
  • Analyst Count
  • SILO 0
  • LGHL 0
  • Target Price
  • SILO N/A
  • LGHL N/A
  • AVG Volume (30 Days)
  • SILO 9.0M
  • LGHL 5.4M
  • Earning Date
  • SILO 02-14-2025
  • LGHL 01-28-2025
  • Dividend Yield
  • SILO N/A
  • LGHL N/A
  • EPS Growth
  • SILO N/A
  • LGHL N/A
  • EPS
  • SILO N/A
  • LGHL N/A
  • Revenue
  • SILO $72,102.00
  • LGHL $13,659,110.00
  • Revenue This Year
  • SILO $1.86
  • LGHL N/A
  • Revenue Next Year
  • SILO N/A
  • LGHL N/A
  • P/E Ratio
  • SILO N/A
  • LGHL N/A
  • Revenue Growth
  • SILO N/A
  • LGHL 11.35
  • 52 Week Low
  • SILO $0.77
  • LGHL $0.13
  • 52 Week High
  • SILO $4.50
  • LGHL $1.55
  • Technical
  • Relative Strength Index (RSI)
  • SILO 79.84
  • LGHL 44.11
  • Support Level
  • SILO $1.62
  • LGHL $0.14
  • Resistance Level
  • SILO $2.16
  • LGHL $0.17
  • Average True Range (ATR)
  • SILO 0.31
  • LGHL 0.03
  • MACD
  • SILO 0.10
  • LGHL -0.00
  • Stochastic Oscillator
  • SILO 43.37
  • LGHL 10.64

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

Share on Social Networks: